| Name | Role |
|---|---|
| William J. Craigen, MD, PhD | Executive Leadership |
| Annette Feigenbaum, MD | Executive Committee |
| Jenny Goldstein, PhD, CGC | Executive Committee |
| Uta Lichter-Konecki, MD | Executive Committee |
| Amanda Thomas, PhD | Executive Committee |
| Diane Zastrow, MS | Executive Committee |
| Meredith Weaver PhD, ScM, CGC | Coordinator |
Please contact a coordinator if you have questions.
Meredith Weaver PhD, ScM, CGC
mweaver@acmg.net
A systematic process of evaluating evidence to classify a genomic variant on a spectrum from pathogenic to benign with respect to a particular disease and inheritance pattern.
